Alpana Sharma

3.7k total citations
131 papers, 2.7k citations indexed

About

Alpana Sharma is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Alpana Sharma has authored 131 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 32 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Alpana Sharma's work include Autoimmune Bullous Skin Diseases (12 papers), Multiple Myeloma Research and Treatments (11 papers) and T-cell and B-cell Immunology (9 papers). Alpana Sharma is often cited by papers focused on Autoimmune Bullous Skin Diseases (12 papers), Multiple Myeloma Research and Treatments (11 papers) and T-cell and B-cell Immunology (9 papers). Alpana Sharma collaborates with scholars based in India, United States and Saudi Arabia. Alpana Sharma's co-authors include Abhigyan Satyam, Medha Rajappa, Jai Bhagwan Sharma, Nidhi Gupta, Vinod Sharma, Vivek Anand, Raman Kumar, Rehan Khan, M. K. Sharma and Sujay Khandpur and has published in prestigious journals such as Cancer Research, ACS Applied Materials & Interfaces and Infection and Immunity.

In The Last Decade

Alpana Sharma

124 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alpana Sharma India 30 788 719 387 380 377 131 2.7k
Xuebin Qin United States 33 1.4k 1.7× 1.1k 1.6× 193 0.5× 207 0.5× 225 0.6× 93 3.6k
Zoe A. Stewart United States 31 392 0.5× 775 1.1× 208 0.5× 120 0.3× 505 1.3× 66 3.1k
Gwenny M. Fuhler Netherlands 31 810 1.0× 1.4k 1.9× 152 0.4× 164 0.4× 571 1.5× 132 3.1k
Ranjit S. Parhar Saudi Arabia 33 1.2k 1.5× 802 1.1× 72 0.2× 135 0.4× 392 1.0× 102 3.1k
Andrea Fattorossi Italy 33 1.0k 1.3× 1.1k 1.5× 135 0.3× 145 0.4× 740 2.0× 141 3.5k
Richard J. Johnson United States 34 547 0.7× 1.4k 1.9× 187 0.5× 266 0.7× 291 0.8× 60 4.4k
Teruhiko Tamaya Japan 34 964 1.2× 1.5k 2.1× 127 0.3× 181 0.5× 613 1.6× 290 4.3k
Bin Zhou China 30 582 0.7× 995 1.4× 73 0.2× 263 0.7× 470 1.2× 184 2.7k
Sophie Lefebvre France 22 1.0k 1.3× 1.1k 1.6× 176 0.5× 117 0.3× 128 0.3× 40 2.4k
Yoshihito Kasahara Japan 32 1.3k 1.7× 1.7k 2.4× 274 0.7× 429 1.1× 457 1.2× 58 3.4k

Countries citing papers authored by Alpana Sharma

Since Specialization
Citations

This map shows the geographic impact of Alpana Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpana Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpana Sharma more than expected).

Fields of papers citing papers by Alpana Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alpana Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpana Sharma. The network helps show where Alpana Sharma may publish in the future.

Co-authorship network of co-authors of Alpana Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Alpana Sharma. A scholar is included among the top collaborators of Alpana Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alpana Sharma. Alpana Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Khandpur, Sujay, et al.. (2024). Augmented IFNγ producing ILC1 and IL 17 producing ILC3 in pemphigus vulgaris: Plausible therapeutic target. Cellular Immunology. 408. 104910–104910. 1 indexed citations
3.
Gupta, Nidhi, et al.. (2023). A Polyherbal Ashwagandha Formulation Exhibits Adjunctive Antitumor Efficacy Against U266 Myeloma Cells by Multi-Strategic Cytotoxic Effects: An Experimental Approach. Asian Pacific Journal of Cancer Prevention. 24(11). 3705–3714. 1 indexed citations
4.
Kumar, Manoj, Harshit Garg, Nidhi Gupta, et al.. (2021). Glucose- regulated protein 78 (GRP78) in renal cell carcinoma: A novel biomarker for predicting tumor behavior. Heliyon. 7(6). e07300–e07300. 9 indexed citations
5.
Gupta, Shalini, Immaculata Xess, Gagandeep Singh, et al.. (2021). Therapeutic implications of candida phenotypes, virulence factors and antifungal sensitivity in Oral leukoplakia. Journal of Oral Biology and Craniofacial Research. 11(2). 354–360. 3 indexed citations
6.
Gupta, Shalini, Alpana Sharma, Nidhi Gupta, & Kalaivani Mani. (2020). Single nucleotide polymorphisms and serologic levels of hypoxia-inducible factor1 α and vascular endothelial growth factor are associated with increased risk of oral submucous fibrosis in gutka users among a North Indian population. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 130(5). 557–564. 4 indexed citations
7.
Das, Dayasagar, et al.. (2019). Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis. Cytokine & Growth Factor Reviews. 45. 35–44. 56 indexed citations
8.
Anand, Vivek, Sandeep Appunni, Amlesh Seth, et al.. (2018). Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A. Molecular and Cellular Biochemistry. 446(1-2). 105–114. 25 indexed citations
9.
Kumar, Raman, Rehan Khan, Nidhi Gupta, et al.. (2017). Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma. Leukemia & lymphoma. 59(7). 1677–1689. 12 indexed citations
10.
Gupta, Nidhi, et al.. (2017). Diagnostic potential of inflammatory biomarkers in early childhood caries - A case control study. Clinica Chimica Acta. 471. 158–163. 30 indexed citations
11.
Gupta, Nidhi, Raman Kumar, & Alpana Sharma. (2016). Versikine, a proteolysis product of Versican: novel therapeutics for multiple myeloma. Translational Cancer Research. 5(7). 1 indexed citations
12.
Khan, Rehan, et al.. (2016). Cinnamon extract exhibits potent anti-proliferative activity by modulating angiogenesis and cyclooxygenase in myeloma cells. Journal of Herbal Medicine. 6(3). 149–156. 16 indexed citations
13.
Chugh, Seema, et al.. (2013). Involvement of Th17 cells in patients of urothelial carcinoma of bladder. Human Immunology. 74(10). 1258–1262. 9 indexed citations
14.
Sharma, Alpana, et al.. (2013). Study of CC chemokine receptor 5 in renal allograft rejection. Indian Journal of Nephrology. 23(3). 196–196. 2 indexed citations
15.
Joshi, Suhasini, et al.. (2010). Oncoproteomics. Clinica Chimica Acta. 412(3-4). 217–226. 15 indexed citations
16.
Rajappa, Medha, et al.. (2009). Oxidant-antioxidant status in Indian patients with carcinoma of posterior one-third of tongue. Cancer Biomarkers. 5(6). 253–260. 19 indexed citations
17.
Rajappa, Medha, Sagnik Sen, & Alpana Sharma. (2008). Role of Pro-/Anti-Inflammatory Cytokines and their Correlation with Established Risk Factors in South Indians with Coronary Artery Disease. Angiology. 60(4). 419–426. 29 indexed citations
18.
Sharma, Alpana, et al.. (2005). Increased levels of Interleukin-4, 5 and 10 and decreased levels of Interleukin-2 and Interferon-gamma in lymphatic filariasis. Biomedical Research-tokyo. 16(1). 0. 1 indexed citations
19.
Rajappa, Medha & Alpana Sharma. (2005). Biomarkers of Cardiac Injury: An Update. Angiology. 56(6). 677–691. 64 indexed citations
20.
Verma, Priyanka, et al.. (1969). Chikungunya Infection to Immunity: An Overview. Current Immunology Reviews. 14. 1–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026